Société des Produits Nestlé S.A.

Société des Produits Nestlé S.A. is a Swiss legal entity within the Nestlé Group. Available corporate and registry references place it in Vevey, in the canton of Vaud, alongside Nestlé’s global headquarters and principal corporate entities. The entity should not be treated automatically as a Philippines-incorporated operating company: although “Nestlé Philippines” is sometimes used as an informal alias in supplied material, the reliable address and legal-entity information identify Société des Produits Nestlé S.A. with Switzerland. Its precise relationship to individual country subsidiaries is not fully established by the available sources. The company name appears in several Nestlé legal, trademark, and intellectual-property contexts. Nestlé Health Science’s terms state that trademarks, logos, characters, and service marks displayed on its platforms belong to the Nestlé Group, and identify Société des Produits Nestlé S.A. in trademark notices. This indicates that the entity has an important role in the group’s intellectual-property and brand architecture, even where products are manufactured, marketed, or sold by other Nestlé companies in particular markets. Public company descriptions also associate Société des Produits Nestlé S.A. with the production and sale of food and beverage products and with Nestlé’s broader work in nutrition, food research, and sustainability. However, those descriptions may aggregate activities performed across the Nestlé corporate family rather than describe a standalone operating business. The available evidence therefore supports describing the subject as a Nestlé-controlled corporate and brand-related entity, rather than assigning it a complete independent product portfolio. Nestlé’s group-wide categories include coffee and tea, confectionery, dairy products and ice cream, infant nutrition, breakfast cereals, culinary products, bottled water, frozen foods, snacks, pet care, dietary supplements, and medical nutrition. Brands commonly associated with the group include Nescafé, KitKat, Maggi, Nesquik, Nespresso, Smarties, and Nestlé Health Science products. These brands should not automatically be interpreted as direct product lines of Société des Produits Nestlé S.A.; the legal entity may hold, license, administer, or support rights used by affiliated operating companies. A registry-derived record gives an incorporation date of 15 December 1936 and identifies the entity as a limited company or société anonyme under Swiss law. It also associates the company with addresses in Vevey and Lausanne. No separate stock ticker, standalone public reporting profile, independently verified chief executive, or reliable evidence of a distinct Philippine headquarters was found in the supplied material. The entity remains active within the Nestlé corporate structure, but its exact operational scope and country-level responsibilities require further verification.

Société des Produits Nestlé S.A. is a Swiss société anonyme associated with the Nestlé Group. The available registry-derived material records an incorporation date of 15 December 1936 and places the entity in the Vevey–Lausanne area of Vaud, Switzerland. The name should be distinguished from Nestlé S.A. itself and from national operating companies that manufacture and sell Nestlé products in particular territories. The entity sits within the legal and commercial infrastructure of one of the world’s largest food and beverage groups. Nestlé’s corporate history reaches back to Henri Nestlé’s infant-food business, established in the nineteenth century, and to the Anglo-Swiss Condensed Milk Company. Those businesses merged in 1905, creating the foundation of the modern Nestlé enterprise. Over the following decades Nestlé expanded from condensed milk and infant nutrition into coffee, dairy, confectionery, culinary products, bottled water, frozen foods, cereals, pet care, dietary supplements, and medical nutrition. Société des Produits Nestlé S.A. was incorporated during this later period of corporate development, although the supplied sources do not establish a detailed account of its original purpose or early management. Modern references show the entity’s continuing importance in brand and intellectual-property administration. Nestlé Health Science terms identify Société des Produits Nestlé S.A. in trademark notices and state that Nestlé Group companies own or control the relevant trademarks, logos, characters, and service marks. Such notices are consistent with a group structure in which legal entities hold or administer rights while country subsidiaries and business divisions handle manufacturing, distribution, advertising, and retail execution. Public business-directory and market-profile descriptions also connect Société des Produits Nestlé S.A. with food and beverage production and sales, nutrition research, food systems, and sustainability. These descriptions should be read cautiously because databases often consolidate information across a multinational corporate family. One directory additionally uses the trading description Centre de Recherche Nestlé, suggesting that the legal name may appear in connection with research activities, but the supplied material does not prove that the subject itself is identical to every Nestlé research operation. The entity has also appeared in Nestlé Health Science transactions. In 2020, Nestlé announced the planned acquisition of Aimmune Therapeutics, bringing the Palforzia peanut-allergy therapy into Nestlé Health Science’s portfolio. In 2024, legal counsel reported representing Société des Produits Nestlé S.A. in the acquisition of substantially all assets of Seres Therapeutics’ VOWST microbiome-therapeutic business, alongside an equity investment. These transactions illustrate the group’s expansion beyond conventional packaged foods into specialized nutrition and health-related products, but they do not establish that the Swiss entity independently commercializes all such products. The supplied input labels the subject as a Philippines entity and provides the alias Nestlé Philippines. Available reliable references instead give Swiss addresses and Swiss legal form. Nestlé’s Philippines operations may be conducted through other local entities, and the evidence provided here is insufficient to map this legal name directly to a Philippine subsidiary. Accordingly, this dossier records Switzerland as the country and headquarters location and marks the identity and country-level operating scope for further review.

• 2024

  VOWST microbiome-business acquisition

  [4]Mayer Brown advises Société des Produits Nestlé on acquisition and equity investmentmayerbrown.com

  Legal counsel reported Société des Produits Nestlé’s purchase of substantially all assets of Seres Therapeutics’ VOWST business, together with a related equity investment.

• 2020

  Expansion into food-allergy treatment

  [5]Nestlé to acquire Aimmune Therapeuticsnestle.com

  Nestlé Health Science announced an agreement to acquire Aimmune Therapeutics and add Palforzia to its food-allergy portfolio.

• 1936

  Swiss legal entity incorporated

  [1]Société des Produits Nestlé S.A. entity and registry profileopensanctions.org

  Registry-derived information records the incorporation of Société des Produits Nestlé S.A. on 15 December 1936 under Swiss-law corporate form.

A Nestlé Group corporate and intellectual-property entity supporting the global food, beverage, nutrition, and health-science portfolio.

• Packaged food and beverages

  Nestlé food and beverage portfolio

  The entity is associated with the Nestlé Group’s broad portfolio of packaged food and beverage categories, including coffee, dairy, confectionery, culinary products, infant nutrition, cereals, snacks, bottled water, and frozen foods. The available evidence does not identify which items are manufactured or sold directly by this legal entity rather than by affiliated companies.

• Medical and specialized nutrition

  Nestlé Health Science portfolio

  Société des Produits Nestlé S.A. appears in legal and transaction contexts connected with Nestlé Health Science. The wider portfolio includes medical nutrition, specialized nutritional formulas, dietary supplements, and food-allergy treatments. Product ownership and commercialization may be allocated among multiple Nestlé entities.

• 2024

  Acquisition of VOWST business assetsM&A

  Background

  Nestlé expanded its health-science activities into microbiome therapeutics through a transaction involving Seres Therapeutics’ VOWST business.

  Action taken

  Société des Produits Nestlé S.A. acquired substantially all assets of the VOWST microbiome-therapeutic business and made a related equity investment.

  Aftermath

  The deal strengthened Nestlé Health Science’s presence in specialized health and therapeutic nutrition, subject to the commercial performance of the acquired business.

  Reported transaction consideration. $235 million upfront, up to $275 million in additional sales milestones, and a $15 million equity investment (2024 transaction announcement)

  Source

• 2020

  Agreement to acquire Aimmune TherapeuticsM&A

  Background

  Nestlé Health Science sought to broaden its food-allergy prevention and treatment activities through Aimmune Therapeutics and its Palforzia therapy.

  Action taken

  Nestlé announced a definitive agreement to acquire Aimmune Therapeutics.

  Aftermath

  The transaction was presented as a way to create a broader food-allergy solution portfolio within Nestlé Health Science.

  Source

• Unconfirmed

  Nestlé Philippines formalizes education-plan agreement with DepEd[7]雀巢菲律宾与教育部正式达成教育计划协议manilatimes.net

  Reported: 2021-01-23

  Nestlé Philippines and the Department of Education formalized an agreement to reinforce implementation of the government’s Basic Education Learning Continuity Plan nationwide.

1. 1Société des Produits Nestlé S.A. entity and registry profileopensanctions.org
2. 2Nestlé Health Science terms and conditionsnestlehealthscience.com
3. 3Nestlé corporate profileen.wikipedia.org
4. 4Mayer Brown advises Société des Produits Nestlé on acquisition and equity investmentmayerbrown.com
5. 5Nestlé to acquire Aimmune Therapeuticsnestle.com
6. 6Société des Produits Nestlé S.A. company profilednb.com
7. 7雀巢菲律宾与教育部正式达成教育计划协议manilatimes.net